IGF1; Somatomedin C
Back to Test Catalogue
Insulin-Like Growth Factor 1 (IGF-1), Serum
Test ID: IGF1EOR S
Orderable by Ontario ND
Test
Aliases/Synonyms
Method
Chemiluminescence Immunoassay
Platform
DiaSorin Liaison XL
Report Includes
Insulin-Like Growth Factor I (IGF-1)
Clinical Utility
IGF-1 testing is useful in several growth-related disorders to help diagnose growth hormone (GH) deficiency or , less commonly, growth hormone excess; to evaluate pituitary function and to monitor effectiveness of GH treatment.
Test Location
The Ottawa Hospital General Campus, 501 Smyth Road, Ottawa ON K1H 8L6
Test Version
22-May-2025
Specimen
Collection Containers
Gold top (clot activator & gel)
Sample Volume
1 mL
Minimum Volume
0.2 mL
Collection & Handling
Handling Information
Store and send frozen.
Stability
| Ambient | 4 hours |
|---|---|
| Refrigerated | 24 hours |
| Frozen | 90 days |
Rejection Criteria
| Hemolysis | Gross |
|---|
Test Version
22-May-2025
Performance / Interpretation
Method
Chemiluminescence Immunoassay
Platform
DiaSorin Liaison XL
Turnaround Time
5 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| Insulin-Like Growth Factor 1 (IGF-1), Serum | µg/L | |||
Sample Reports
Test Location
The Ottawa Hospital General Campus, 501 Smyth Road, Ottawa ON K1H 8L6
Test Version
22-May-2025
Interface / Setup
HL7 Interface Codes
| Order Code | Result Codes | Units |
|---|---|---|
| IGF1EOR S | 63761IGF-1 | ug/L |
Sample Reports
Test Version
22-May-2025